Fibrogen logo

Fibrogen Share Price Today

(NASDAQ: FGEN)

Fibrogen share price is $0.39 & ₹33.92 as on 6 Mar 2025, 2.30 'hrs' IST

$0.39

0.03

(9.32%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Fibrogen share price in Dollar and Rupees. Guide to invest in Fibrogen stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Fibrogen, along with analyst recommendations, forecasts, and comprehensive financials.

Fibrogen share price movements

  • Today's Low: $0.35
    Today's High: $0.40

    Day's Volatility :11.98%

  • 52 Weeks Low: $0.18
    52 Weeks High: $2.80

    52 Weeks Volatility :93.57%

Fibrogen (FGEN) Returns

PeriodFibrogen IncSector (Health Care)Index (Russel 2000)
3 Months
-2.79%
3.7%
0.0%
6 Months
-7.34%
-2.8%
0.0%
1 Year
-78.93%
2.5%
0.0%
3 Years
-96.9%
12.9%
-11.6%

Fibrogen (FGEN) Key Statistics

in dollars & INR

Previous Close
$0.3604
Open
$0.352
Today's High
$0.3999
Today's Low
$0.352
Market Capitalization
$36.3M
Today's Volume
$753.3K
52 Week High
$2.8
52 Week Low
$0.18
Revenue TTM
$180.0M
EBITDA
$-114.8M
Earnings Per Share (EPS)
$-1.23
Profit Margin
-67.66%
Quarterly Earnings Growth YOY
0.54%
Return On Equity TTM
-1015.79%

How to invest in Fibrogen Stock (FGEN) from India?

It is very easy for Indian residents to invest directly in Fibrogen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fibrogen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Fibrogen or FGEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fibrogen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fibrogen shares which would translate to 2.230 fractional shares of Fibrogen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Fibrogen, in just a few clicks!

Returns in Fibrogen (FGEN) for Indian investors in Rupees

The Fibrogen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Fibrogen investment value today

Current value as on today

₹25,804

Returns

₹74,196

(-74.2%)

Returns from Fibrogen Stock

₹79,144 (-79.14%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Fibrogen (FGEN)

475.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Fibrogen Shares from India has grown by 475.0% over the past 30 days, indicating increased transactional activity.

40%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Fibrogen Stock from India on INDmoney has increased by 40% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Fibrogen

  • Armistice Capital, LLC

    6.75%

  • Vanguard Group Inc

    5.83%

  • PRIMECAP Management Company

    4.58%

  • BlackRock Inc

    2.36%

  • 683 Capital Management LLC

    2.12%

  • Renaissance Technologies Corp

    1.35%

Analyst Recommendation on Fibrogen

Sell

    0%Buy

    37%Hold

    62%Sell

Based on 8 Wall street analysts offering stock ratings for Fibrogen(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
4
Sell
5
5
5

Analyst Forecast on Fibrogen Stock (FGEN)

What analysts predicted

Upside of 2464.1%

Target:

$10.00

Current:

$0.39

Insights on Fibrogen Stock (Ticker Symbol: FGEN)

  • Price Movement

    In the last 3 months, FGEN stock has moved up by 15.2%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 55.90M → 46.33M (in $), with an average decrease of 9.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -15.54M → -17.08M (in $), with an average decrease of 9.9% per quarter
  • FGEN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 145.4%
  • FGEN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 148.6%
  • Price to Sales

    ForFGEN every $1 of sales, investors are willing to pay $0.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

FGEN Fibrogen Financials in INR & Dollars

FY18Y/Y Change
Revenue
$213.0M
↑ 69.46%
Net Income
$-86.4M
↓ 31.52%
Net Profit Margin
-40.58%
↑ 59.85%
FY19Y/Y Change
Revenue
$256.6M
↑ 20.48%
Net Income
$-77.0M
↓ 10.93%
Net Profit Margin
-30.0%
↑ 10.58%
FY20Y/Y Change
Revenue
$176.3M
↓ 31.28%
Net Income
$-189.3M
↑ 145.93%
Net Profit Margin
-107.36%
↓ 77.36%
FY21Y/Y Change
Revenue
$235.3M
↑ 33.46%
Net Income
$-291.0M
↑ 53.75%
Net Profit Margin
-123.68%
↓ 16.32%
FY22Y/Y Change
Revenue
$140.7M
↓ 40.19%
Net Income
$-295.2M
↑ 1.44%
Net Profit Margin
-209.78%
↓ 86.1%
FY23Y/Y Change
Revenue
$147.8M
↑ 4.99%
Net Income
$-284.2M
↓ 3.72%
Net Profit Margin
-192.37%
↑ 17.41%
Q2 FY23Q/Q Change
Revenue
$44.3M
↑ 22.56%
Net Income
$-87.7M
↑ 13.13%
Net Profit Margin
-197.84%
↑ 16.48%
Q3 FY23Q/Q Change
Revenue
$40.1M
↓ 9.44%
Net Income
$-63.6M
↓ 27.45%
Net Profit Margin
-158.51%
↑ 39.33%
Q4 FY23Q/Q Change
Revenue
$27.1M
↓ 32.38%
Net Income
$-56.2M
↓ 11.61%
Net Profit Margin
-207.21%
↓ 48.7%
Q1 FY24Q/Q Change
Revenue
$55.9M
↑ 105.99%
Net Income
$-32.9M
↓ 41.43%
Net Profit Margin
-58.91%
↑ 148.3%
Q2 FY24Q/Q Change
Revenue
$50.6M
↓ 9.41%
Net Income
$-15.5M
↓ 52.8%
Net Profit Margin
-30.69%
↑ 28.22%
Q3 FY24Q/Q Change
Revenue
$46.3M
↓ 8.51%
Net Income
$-17.1M
↑ 9.91%
Net Profit Margin
-36.87%
↓ 6.18%
FY18Y/Y Change
Profit
$213.0M
↑ 69.46%
FY19Y/Y Change
Profit
$255.4M
↑ 19.94%
FY20Y/Y Change
Profit
$167.5M
↓ 34.44%
FY21Y/Y Change
Profit
$222.4M
↑ 32.84%
FY22Y/Y Change
Profit
$120.5M
↓ 45.85%
FY23Y/Y Change
Profit
$128.9M
↑ 7.02%
Q2 FY23Q/Q Change
Profit
$38.6M
↑ 18.18%
Q3 FY23Q/Q Change
Profit
$35.9M
↓ 7.04%
Q4 FY23Q/Q Change
Profit
$21.7M
↓ 39.45%
Q1 FY24Q/Q Change
Profit
$30.1M
↑ 38.74%
Q2 FY24Q/Q Change
Profit
$45.5M
↑ 50.79%
Q3 FY24Q/Q Change
Profit
$41.0M
↓ 9.73%
FY18Y/Y Change
Operating Cash Flow
$-76.1M
↑ 14.48%
Investing Cash Flow
$-522.1M
↓ 847.32%
Financing Cash Flow
$13.9M
↓ 97.21%
FY19Y/Y Change
Operating Cash Flow
$-78.7M
↑ 3.36%
Investing Cash Flow
$120.0M
↓ 122.99%
Financing Cash Flow
$-4.3M
↓ 130.99%
FY20Y/Y Change
Operating Cash Flow
$81.6M
↓ 203.68%
Investing Cash Flow
$452.5M
↑ 277.02%
Financing Cash Flow
$13.3M
↓ 410.3%
FY21Y/Y Change
Operating Cash Flow
$-82.2M
↓ 200.77%
Investing Cash Flow
$-427.0M
↓ 194.36%
Financing Cash Flow
$-563.0K
↓ 104.22%
FY22Y/Y Change
Operating Cash Flow
$-145.9M
↑ 77.46%
Investing Cash Flow
$89.1M
↓ 120.87%
Financing Cash Flow
$46.8M
↓ 8408.35%
Q2 FY23Q/Q Change
Operating Cash Flow
$-110.6M
↑ 8.84%
Investing Cash Flow
$-14.3M
↓ 113.8%
Financing Cash Flow
$91.5M
↑ 190.72%
Q3 FY23Q/Q Change
Operating Cash Flow
$-84.5M
↓ 23.54%
Investing Cash Flow
$54.2M
↓ 479.54%
Financing Cash Flow
$-22.0K
↓ 100.02%

Fibrogen Technicals Summary

Sell

Neutral

Buy

Fibrogen is currently in a neutral trading position according to technical analysis indicators.

Fibrogen (FGEN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fibrogen Inc logo
-14.94%
-7.34%
-78.93%
-96.9%
-98.93%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fibrogen Inc logo
NA
NA
0.0
-0.86
-10.16
-0.21
NA
-2.42
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fibrogen Inc logo
Sell
$36.3M
-98.93%
NA
-67.66%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Fibrogen

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Organization
Fibrogen
Employees
486
CEO
Mr. Thane Wettig
Industry
Health Technology

Management People of Fibrogen

NameTitle
Mr. Thane Wettig
CEO & Director
Mr. David DeLucia
Chief Financial Officer
Mr. Michael D. Lowenstein J.D., Ph.D.
Chief Legal Officer
Mr. Julian N. Stern
Secretary

Important FAQs about investing in FGEN Stock from India :

What is Fibrogen share price today?

Fibrogen share price today stands at $0.39, Open: $0.35 ; Previous Close: $0.36 ; High: $0.40 ; Low: $0.35 ; 52 Week High: $2.80 ; 52 Week Low: $0.18.

The stock opens at $0.35, after a previous close of $0.36. The stock reached a daily high of $0.40 and a low of $0.35, with a 52-week high of $2.80 and a 52-week low of $0.18.

Can Indians buy Fibrogen shares?

Yes, Indians can invest in the Fibrogen (FGEN) from India.

With INDmoney, you can buy Fibrogen at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Fibrogen at zero transaction cost.

How can I buy Fibrogen shares from India?

It is very easy to buy Fibrogen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Fibrogen (FGEN) be purchased?

Yes, you can buy fractional shares of Fibrogen with INDmoney app.

What are the documents required to start investing in Fibrogen stocks?

To start investing in Fibrogen, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Fibrogen Stock (FGEN)?

Today’s highest price of Fibrogen (FGEN) is $0.40.

Today’s lowest price of Fibrogen (FGEN) is $0.35.

What is today's market capitalisation of Fibrogen?

Today's market capitalisation of Fibrogen FGEN is 36.3M

What is the 52 Week High and Low Range of Fibrogen Stock (FGEN)?

  • 52 Week High

    $2.80

  • 52 Week Low

    $0.18

What are the historical returns of Fibrogen (FGEN)?

  • 1 Month Returns

    -14.94%

  • 3 Months Returns

    -7.34%

  • 1 Year Returns

    -78.93%

  • 5 Years Returns

    -98.93%

Who is the Chief Executive Officer (CEO) of Fibrogen ?

Mr. Thane Wettig is the current Chief Executive Officer (CEO) of Fibrogen.